Bausch Health's Leadership Set to Attend the J.P. Morgan Healthcare Conference in San Francisco

Bausch Health Attending the 44th Annual J.P. Morgan Healthcare Conference

Bausch Health Companies Inc., a leading global pharmaceutical company, is gearing up for a prominent appearance at the upcoming 44th Annual J.P. Morgan Healthcare Conference. The event, set to take place on January 14, 2026, in San Francisco, promises to be a significant milestone for the company and its stakeholders.

Event Details

During this year’s conference, Bausch Health will be represented by its Chief Executive Officer, Thomas J. Appio, alongside key executives, including Jean-Jacques (JJ) Charhon, Executive Vice President and Chief Financial Officer, and Jonathan Sadeh, M.D., Executive Vice President, Chief Medical Officer, and Head of Research and Development. Their presence emphasizes the company’s commitment to open communication and transparency with investors and health care professionals.

The scheduled time for their presentation is 3:45 p.m. PT (6:45 p.m. ET). Interested stakeholders are encouraged to tune in to the live audio webcast available in the Investor Relations section of the Bausch Health website. A recording of the session will also be accessible after the event for those unable to participate live. This initiative reflects the company’s relentless pursuit of enhancing health care outcomes and its dedication to keeping investors informed.

Bausch Health's Commitment

Bausch Health strives to deliver innovative pharmaceutical solutions across various areas, including gastroenterology, hepatology, neurology, dermatology, aesthetics, and eye health. The company maintains a strong relationship with its subsidiary, Bausch + Lomb Corporation, which focuses on developing leading eye health products. Through strategic collaborations and a diversified portfolio, Bausch Health aims to become a globally integrated health care company that is trusted and valued by patients, healthcare providers, employees, and investors alike.

Industry Impact

The J.P. Morgan Healthcare Conference is a pivotal event in the healthcare industry, drawing attention from various stakeholders, including analysts, investors, and policymakers. Participating in this conference allows Bausch Health to showcase its latest research, development initiatives, and business strategies. This forum facilitates essential discussions on market trends and innovations, which can ultimately influence the company’s direction and its impact on global health care.

Looking Ahead

Beyond the conference, Bausch Health is focused on future growth and the creation of positive health outcomes. Their commitment to transformative health care solutions is evidenced by a pipeline of promising products and an ongoing pursuit of scientific advancements. The company’s forward-looking approach, coupled with its established presence at major industry events, positions Bausch Health as a key player in the healthcare market.

For additional information on Bausch Health's participation and their full range of health care products, visit Bausch Health Investor Relations. Stay updated on future developments and health care advancements through Bausch Health's channels as they continue to push boundaries in the pharmaceutical realm.

This announcement exemplifies Bausch Health's dedication to shaping the future of health care while ensuring their stakeholders remain well-informed and engaged. As the healthcare landscape continues to evolve, Bausch Health remains committed to delivering quality care and innovative solutions for a healthier tomorrow.